Free Trial

Integra LifeSciences (IART) Competitors

Integra LifeSciences logo
$15.08 +0.47 (+3.22%)
Closing price 10/17/2025 04:00 PM Eastern
Extended Trading
$15.08 -0.01 (-0.03%)
As of 10/17/2025 04:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IART vs. ITGR, ATEC, ATRC, OFIX, ANGO, SRDX, ARAY, RMTI, ABT, and ISRG

Should you be buying Integra LifeSciences stock or one of its competitors? The main competitors of Integra LifeSciences include Integer (ITGR), Alphatec (ATEC), AtriCure (ATRC), Orthofix Medical (OFIX), AngioDynamics (ANGO), Surmodics (SRDX), Accuray (ARAY), Rockwell Medical (RMTI), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "health care equipment" industry.

Integra LifeSciences vs. Its Competitors

Integer (NYSE:ITGR) and Integra LifeSciences (NASDAQ:IART) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation, institutional ownership and media sentiment.

Integer has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500. Comparatively, Integra LifeSciences has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500.

99.3% of Integer shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 2.2% of Integer shares are held by insiders. Comparatively, 3.5% of Integra LifeSciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Integer had 4 more articles in the media than Integra LifeSciences. MarketBeat recorded 6 mentions for Integer and 2 mentions for Integra LifeSciences. Integer's average media sentiment score of 0.57 beat Integra LifeSciences' score of 0.00 indicating that Integer is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integer
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Integra LifeSciences
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Integer has a net margin of 4.61% compared to Integra LifeSciences' net margin of -30.87%. Integer's return on equity of 12.27% beat Integra LifeSciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Integer4.61% 12.27% 6.23%
Integra LifeSciences -30.87%12.15%4.32%

Integer currently has a consensus target price of $137.29, indicating a potential upside of 30.92%. Integra LifeSciences has a consensus target price of $16.17, indicating a potential upside of 7.21%. Given Integer's stronger consensus rating and higher possible upside, equities analysts clearly believe Integer is more favorable than Integra LifeSciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.89
Integra LifeSciences
4 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.75

Integer has higher revenue and earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integer$1.79B2.05$119.90M$2.2746.20
Integra LifeSciences$1.61B0.73-$6.94M-$6.53-2.31

Summary

Integer beats Integra LifeSciences on 15 of the 17 factors compared between the two stocks.

Get Integra LifeSciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IART and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IART vs. The Competition

MetricIntegra LifeSciencesMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.17B$7.18B$6.21B$10.54B
Dividend YieldN/A1.16%5.70%4.81%
P/E Ratio-2.3127.9085.7027.13
Price / Sales0.7327.67603.21187.86
Price / Cash3.3921.9437.1060.81
Price / Book0.755.1512.236.52
Net Income-$6.94M$179.79M$3.33B$276.93M
7 Day Performance13.04%0.20%1.17%1.93%
1 Month Performance6.72%1.97%6.85%2.19%
1 Year Performance-24.11%1.75%58.93%34.62%

Integra LifeSciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IART
Integra LifeSciences
2.6632 of 5 stars
$15.08
+3.2%
$16.17
+7.2%
-24.1%$1.17B$1.61B-2.314,396Analyst Forecast
ITGR
Integer
3.7461 of 5 stars
$105.33
+0.3%
$139.57
+32.5%
-19.6%$3.68B$1.72B46.4011,000Positive News
Upcoming Earnings
Analyst Forecast
ATEC
Alphatec
4.0758 of 5 stars
$13.60
-2.6%
$18.50
+36.0%
+162.6%$2.07B$611.56M-12.04700News Coverage
Positive News
Analyst Forecast
ATRC
AtriCure
2.9516 of 5 stars
$34.73
-0.2%
$50.89
+46.5%
+29.1%$1.73B$465.31M-45.101,300
OFIX
Orthofix Medical
1.8691 of 5 stars
$14.17
-3.0%
$21.75
+53.5%
-6.2%$577.01M$799.49M-4.471,616
ANGO
AngioDynamics
4.3713 of 5 stars
$11.26
-3.3%
$19.33
+71.7%
+80.6%$479.57M$292.50M-14.44760Positive News
SRDX
Surmodics
4.3892 of 5 stars
$28.70
-1.4%
$43.00
+49.8%
-26.8%$416.35M$126.08M-23.33450Positive News
ARAY
Accuray
3.9943 of 5 stars
$1.71
+1.2%
$5.00
+192.4%
-10.6%$190.50M$458.51M-85.501,040
RMTI
Rockwell Medical
3.7505 of 5 stars
$1.21
-0.8%
$4.00
+230.6%
-66.2%$42.01M$101.49M-20.17300News Coverage
Gap Down
ABT
Abbott Laboratories
4.958 of 5 stars
$133.63
-0.7%
$145.39
+8.8%
+7.8%$234.25B$41.95B16.75114,000Trending News
Earnings Report
Analyst Forecast
Analyst Revision
ISRG
Intuitive Surgical
4.926 of 5 stars
$449.69
-0.6%
$594.19
+32.1%
-14.4%$162.16B$8.35B62.7215,638Trending News
Upcoming Earnings
Analyst Forecast
Short Interest ↑
Analyst Revision

Related Companies and Tools


This page (NASDAQ:IART) was last updated on 10/19/2025 by MarketBeat.com Staff
From Our Partners